Border-wall talks ‘a waste of money and time,’ Trump says
President suggests he’ll issue emergency order to build wall in N.Y. Times interview
All Posts in "Markets"
Here is what the stock market’s monster January rally means for February
The Fed’s dovish stance likely to further lift stocks
Gold prices settle higher, up a 4th month in a row
Fed’s posture suggest rate hikes are on pause
Apple stock rallies after weak forecast, but analysts say company isn’t out of the woods
China woes and pricing issues expected to persist, while Apple Care trends could hurt services segment
House Democrats roll out bill that would expand Social Security
Social Security 2100 Act would gradually ramp up how much workers and employers contribute
Facebook reports record profit, stock surges more than 12% after earnings
Facebook adds 1 million daily users in the U.S. and Canada despite constant controversy
Bitcoin bounces off 2019 low after entering technically oversold territory
XRP leads altcoins higher, rising 10%
Stocks end mostly lower on big day for earnings
Federal Reserve kicks set to provide a policy update Wednesday
Apple revenue should continue to shrink, so why is the stock up?
Below-consensus forecast was still better than feared, analyst says, and positive disclosures about the services business buoys Apple — for now
GameStop says it’s no longer for sale, stock promptly plummets
Stock on track for biggest one-day selloff since December of 2002 as Jefferies and Baird downgrade to neutral from buy
Galapagos investor signals intent to influence company’s control, argues the biotech is ‘deeply undervalued’
Dexcom’s Stelo, its first over-the-counter glucose monitor, hits the market
Procept BioRobotics stock jumps on FDA nod for prostate surgery system
Understanding how pythons swallow massive meals may help develop new human heart medicines
Lykos’ woes mount as FDA expands probe into its MDMA-based research: WSJ
After phase 2 fail, Actinogen reports new data in bid to salvage depression drug xanamem
MBX files for IPO, seeking cash to take challenger to Ascendis’ Yorvipath into phase 3
Preclinical gene editor Tome is laying off 131 staffers, virtually its entire workforce
Bicara and Zenas file for IPOs to push late-phase prospects toward finish line
Tweaking one setting on mechanical ventilators may help protect patients from lung injury